Is MEDIFAST INC (MED) overvalued? · rev $602.5M
MEDIFAST INC (MED) is a personal services company listed on NYSE.
This page asks whether MEDIFAST INC (MED) looks expensive on cached numbers — not a short thesis.
Latest reported MED revenue for 2024-12-31 was $602.5M. Net income was $2.1M. Revenue was down 43.8% from 2023-12-31 to 2024-12-31. MED currently screens at market cap $125.3M.
MED currently screens at market cap $125.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MED 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MED stock page for the full model, not this heading.
Not investment advice.